Back to Search
Start Over
Efficacy and safety of DBPR108 monotherapy in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled, phase II clinical trial
- Source :
- Current Medical Research and Opinion. 36:1107-1115
- Publication Year :
- 2020
- Publisher :
- Informa UK Limited, 2020.
-
Abstract
- Objective: DBPR108, a novel dipeptidyl-peptidase-4 inhibitor, has shown great antihyperglycemic effect in animal models. This study was to evaluate the efficacy and safety of DBPR108 monotherapy in...
- Subjects :
- Adult
Male
medicine.medical_specialty
Time Factors
Type 2 diabetes
030204 cardiovascular system & hematology
Placebo
Double blind
03 medical and health sciences
0302 clinical medicine
Double-Blind Method
Internal medicine
medicine
Humans
Hypoglycemic Agents
In patient
030212 general & internal medicine
Aged
Glycated Hemoglobin
Dipeptidyl-Peptidase IV Inhibitors
business.industry
Type 2 Diabetes Mellitus
General Medicine
Middle Aged
medicine.disease
Clinical trial
Diabetes Mellitus, Type 2
Female
business
Subjects
Details
- ISSN :
- 14734877 and 03007995
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Current Medical Research and Opinion
- Accession number :
- edsair.doi.dedup.....342918a5c28c95143fe087ce9efd413d